Enovix Co. (NASDAQ:ENVX – Get Free Report) has been given an average rating of “Moderate Buy” by the eleven analysts that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $20.50.
ENVX has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their price target on Enovix from $18.00 to $15.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Benchmark reiterated a “buy” rating and issued a $25.00 target price on shares of Enovix in a research note on Wednesday, October 30th. Janney Montgomery Scott lowered Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target on the stock. in a research report on Thursday, October 31st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a research report on Wednesday, October 30th.
Read Our Latest Stock Report on Enovix
Enovix Stock Down 9.6 %
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.03. The company had revenue of $4.30 million during the quarter, compared to analyst estimates of $4.11 million. Enovix had a negative net margin of 1,180.21% and a negative return on equity of 102.19%. During the same quarter in the prior year, the business earned ($0.27) earnings per share. Equities analysts forecast that Enovix will post -1.17 earnings per share for the current year.
Insider Buying and Selling at Enovix
In other Enovix news, Director Betsy S. Atkins sold 75,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the sale, the director now owns 99,497 shares in the company, valued at $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. 15.70% of the stock is currently owned by insiders.
Institutional Investors Weigh In On Enovix
A number of institutional investors have recently made changes to their positions in the company. Prospera Private Wealth LLC bought a new stake in Enovix during the third quarter valued at $27,000. Fifth Third Bancorp boosted its holdings in shares of Enovix by 66.7% in the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock valued at $27,000 after buying an additional 1,000 shares during the period. Strategic Investment Solutions Inc. IL bought a new position in shares of Enovix during the second quarter valued at approximately $39,000. R Squared Ltd bought a new position in Enovix during the 4th quarter worth $64,000. Finally, Voisard Asset Management Group Inc. increased its position in Enovix by 40.0% in the third quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock worth $65,000 after buying an additional 2,000 shares during the period. 50.92% of the stock is currently owned by institutional investors.
Enovix Company Profile
Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Articles
- Five stocks we like better than Enovix
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Sizing Up a New Opportunity for NVIDIA Investors
- What is the Euro STOXX 50 Index?
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- What Are the FAANG Stocks and Are They Good Investments?
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.